Bioengineering Institute

What Bioengineering Institute does

The Instituto de Bioingeniería (IB) is an interdisciplinary research center within Universidad Miguel Hernández (UMH), a public university in Elche, Spain. Founded in 1996, the institute is organized into 7 research units and 19 research groups and employs more than 100 researchers and support staff. Its research spans biomedical neuroengineering (including visual neuroprosthetics and brain-machine interfaces), medical robotics and regenerative medicine, structural and functional plant genomics, toxicology and clinical drug monitoring, organic molecule synthesis for nanotechnology and biotechnology, biomaterials, advanced optical imaging, applied zoology, biophysics, and cellular regenerative therapy. The institute does not commercialize products or hold patents; its outputs are scientific publications, competitive grant capture, and trained researchers.

IB's business model is non-commercial. It is funded through regional, national, and European research programs, public grants, university allocations, and competitive funding instruments. The institute also operates two formal educational programs, a Master's Degree in Biotechnology and Bioengineering and a Doctoral Program in Bioengineering, both structured around seminar series featuring international researchers. Its customers, in the stakeholder sense, are graduate and doctoral students, international academic and clinical collaborators (including Stanford, Cambridge, UCSD, Leiden University Medical Center, IIT Indore, and IBEC), and Spanish healthcare partners (Hospital de la Marina de Denia, Fisabio Foundation). The institute's go-to-market is community-led: visibility and reputation are built through seminar hosting, scientific conferences, and outreach events such as DivulgaNobel rather than through commercial sales motions. Governance is led by Director Eduardo Fernández Jover (Biomedical Neuroengineering), Subdirector Nicolás García Aracil (Robotics and Artificial Intelligence), and Secretary Pablo Velásquez Castillo (Biomaterials).

Name

Bioengineering Institute

Legal name

Instituto de Bioingeniería - Universidad Miguel Hernández de Elche

Website

https://bioingenieria.umh.es

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

The Instituto de Bioingeniería is an interdisciplinary public university research center at Universidad Miguel Hernández in Elche, Spain, conducting bioengineering research and training graduate students across 7 research units and 19 research groups.

Ownership category

akta.pro rank

Product category

Academic Bioengineering Research

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

akta.pro secondary industries

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC), Regenerative Immunology & Inflammation Modulation (pro-regenerative biologics) (HLAAAGAL)

Keywords

• Interdisciplinary bioengineering research
• Biomedical neuroengineering research
• Medical robotics research
• Regenerative medicine research
• Graduate biotechnology education

Headquarters

HQ city

Elche

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Public institutional funding: Funded through regional, national, and European research programs, public grants, and university allocations. No commercial revenue model applies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

The Bioengineering Institute is an interdisciplinary university research center that conducts scientific research across biomedical neuroengineering, medical robotics, regenerative medicine, food quality and safety, plant genomics, toxicology, drug monitoring, organic synthesis, biomaterials, optical imaging, applied zoology, biophysics, and cellular regenerative therapy. It also delivers graduate education through a Master's in Biotechnology and Bioengineering and a Doctoral Program in Bioengineering, and hosts international scientific seminars. The institute is publicly funded and does not sell commercial products.

Product overview

The Bioengineering Institute (Instituto de Bioingeniería) at Miguel Hernández University is an interdisciplinary research center organized into 7 research units and 19 research groups with over 100 researchers. The institute conducts research across diverse areas including biomedical neuroengineering, medical robotics, regenerative medicine, food quality and safety, plant genomics, toxicology, clinical trials, molecular synthesis for nanotechnology, biomaterials development, advanced optical imaging, and regenerative cellular therapy. The institute also offers educational programs including a Master's Degree in Biotechnology and Bioengineering and a Doctoral Program in Bioengineering, both featuring seminar programs with international researchers.

Differentiator

Problem solved

Functional benefit

Products and services

• Master's Degree in Biotechnology and Bioengineering

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

17 partnerships are on record, tiered core and minor.

• Leiden University Medical Center (LUMC), NetherlandscoreStrategic or Co-development Partner · 1 January 2025Ongoing research collaboration evidenced by postdoctoral researcher Jeniffer Sanguino Gómez's affiliation. Her work on stress, cognition, and behavioral sequencing is conducted in partnership with LUMC, with seminars delivered at IB.
• Indian Institute of Technology (IIT) IndorecoreStrategic or Co-development Partner · 1 January 2025Prof. Rajneesh Misra from IIT Indore delivered seminars at IB and has joint publication/collaboration interests in luminescent materials, phenothiazine derivatives, and optoelectronic devices.
• CSIC-UMH Institute of Neurosciences, AlicantecoreStrategic or Co-development Partner · 1 January 2025Dr. Maximilian Eggl, a researcher at the CSIC-UMH Institute of Neurosciences, delivers seminars and collaborates on neuroinflammation research via diffusion-weighted MRI, hosted at IB.
• Hospital de la Marina de DeniacoreStrategic or Co-development Partner · 1 January 2025Dr. Joan Manel Gasent from the Oncology Service of Hospital de la Marina de Denia delivers seminars at IB on molecular perspectives in neoplasms, indicating clinical-academic collaboration.
• Universidad Simón Bolívar, Caracas, VenezuelaminorStrategic or Co-development Partner · 1 January 2025Dra. Delia Gutierrez Campos (Professor of Materials Science) delivered seminars on fracture toughness of refractory materials, organized by Dra. Piedad De Aza of IB.
• Stanford UniversitycoreStrategic or Co-development Partner · 1 January 2024Dr. Mohajeet Balvoer Bhuckhory from Stanford University delivered seminars on photovoltaic retinal implants and visual restoration, with ongoing collaboration with IB director Eduardo Fernández on subretinal artificial vision devices.
• University of California San Diego (UCSD) / Center for Circadian BiologycoreStrategic or Co-development Partner · 1 January 2024Prof. José Pruneda-Paz (UCSD) delivered seminars on plant circadian rhythms and daily rhythms, with IB researchers including José Luis Micol and Juan José Ripoll Samper organizing and co-hosting.
• Donders Centre for Neuroscience, Radboud University, NetherlandscoreStrategic or Co-development Partner · 1 January 2024Prof. Richard van Wezel (Director of Health OnePlanet Research Center) delivered seminars on visual prosthetics and neural adaptation, with IB director Eduardo Fernández involved as host/organizer.
• Institute for Bioengineering of Catalonia (IBEC)coreStrategic or Co-development Partner · 1 January 2024Dr. Pau Gorostiza from IBEC delivered seminars on photopharmacology and remote control of neuronal activity, hosted by IB researchers.
• International Center for Aging Research (ICAR)coreStrategic or Co-development Partner · 1 January 2024IB Director Eduardo Fernández participated in ICAR-funded research project (one of 36 selected, total funding of one million euros), presented at Longevity World Forum in Alicante.
• Fisabio FoundationminorStrategic or Co-development Partner · 1 January 2024IB participates in UniSalut collaboration project with Fisabio Foundation, with IB director Eduardo Fernández and innovation agent Vanessa Zorrilla Muñoz engaging in creativity workshops and joint project development.
• Cajal-Roche Chair / Royal National Academy of MedicinecoreStrategic or Co-development Partner · 1 January 2024IB director Eduardo Fernández participated in the II Cajal-Roche Chair Symposium at the Royal National Academy of Medicine in Madrid, focusing on neuroscience and health technologies.
• Universitat Jaume I de CastellócoreStrategic or Co-development Partner · 1 January 2023Multiple collaborative seminars involving researchers such as Dr. Eduardo Peris (supramolecular catalysis), Dr. Vicent Arbona Mengual (plant-arthropod interactions), and Prof. Gladys Míng EZ (nanomaterials synthesis), indicating ongoing research ties.
• University of AlicantecoreStrategic or Co-development Partner · 1 January 2023Dr. Andrés Ubeda Castellanos (Full Professor, University of Alicante) delivered seminars on electromyography applications in rehabilitation, organized by IB researcher Nicolás García Aracil.
• Universidade Federal da Bahia (UFBA), BrazilminorStrategic or Co-development Partner · 1 January 2023Dr. Alfonso Gala García from UFBA delivered seminars on biomaterials for dental tissue regeneration, organized by Prof. Piedad de Aza of IB.
• University of CambridgecoreStrategic or Co-development Partner · 1 January 2022Dr. Facundo Romani from Cambridge delivered seminars on Marchantia transcription factors, organized by Prof. José Manuel Pérez Pérez from IB.
• CINVESTAV-MexicominorStrategic or Co-development Partner · 1 January 2022Dr. July Andrea Rincón López (CINVESTAV-Mexico) delivered seminars on 3D bioprinting and bioceramics for bone repair, organized by Prof. Piedad de Aza of IB.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Technical University of Madrid — Centre for Biomedical Technology (CTB): Madrid-based university-affiliated research center covering biomedical engineering, computational biology, and neurotechnology — directly comparable in academic bioengineering research focus and Spanish university institutional setting, making it a natural peer for collaborative competition in Spanish biomedical engineering.
• Institute for Bioengineering of Catalonia (IBEC): Barcelona-based bioengineering research institute that is IB's closest Spanish peer in mission, scope, and stage; both are university-affiliated interdisciplinary bioengineering centers covering biomaterials, nanomedicine, and cellular/biomedical engineering, and IBEC's Dr. Gorostiza already collaborates directly with IB via seminar partnerships.
• Institute of Molecular Biology (IBMB) — University of Barcelona: Spanish university-based molecular biology/biomedical research institute of similar scale and structure to IB; provides a directly comparable model for how university-affiliated Spanish research institutes organize interdisciplinary research, funding, and graduate training.
• CSIC-UMH Institute of Neurosciences: Neuroscience research institute jointly operated by CSIC and UMH on the same Elche campus as IB; shares the neuroengineering/neuroscience research domain, and Dr. Eggl from this institute already collaborates with IB on neuroinflammation diffusion-weighted MRI research.
• Príncipe Felipe Research Center (CIPF): Valencian biomedical research center in the same Spanish region as IB, focused on neuroscience, rare diseases, and regenerative medicine — directly overlapping with IB's neuroengineering, biomaterials, and regenerative cellular therapy research lines, and part of the same regional scientific ecosystem.
• Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER): Spanish research center combining molecular biology, regenerative medicine, and biomaterials — a comparable Spanish peer whose regenerative cellular therapy and biomaterials programs directly parallel IB's research areas, including bone repair and dental tissue regeneration work IB hosts seminars on.

Broad incumbents

• Max Planck Institute for Molecular Biomedicine: Established European research institute operating at significantly larger scale in molecular biomedicine, vascular biology, and regenerative medicine; serves as a broader incumbent reference point for how interdisciplinary bio/biomedical research institutes scale teams and infrastructure.
• Centro de Investigación Biomédica en Red (CIBER): Large Spanish networked consortium of biomedical research groups covering rare diseases, neurodegenerative diseases, and bioengineering-relevant areas — represents a broader incumbent umbrella under which IB-aligned research themes are coordinated nationally.

Regional players

• Biogipuzkoa Health Research Institute: Spanish regional biomedical research institute (Basque Country) that combines clinical and basic bioengineering-adjacent research; comparable in governance structure as a Spanish regional health-research institute, though primarily Basque-focused rather than Mediterranean like IB.

Others

• Fisabio Foundation: Valencian public foundation promoting health research and innovation; already a documented partner of IB through the UniSalut collaboration project, and represents the adjacent regional ecosystem player through which IB's research is funneled into healthcare innovation outcomes.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/IB_UMH
• YouTubeyoutube.com/@InstitutodeBioingenieria
• LinkedInlinkedin.com/company/instituto-de-bioingenier%C3%ADa-de-la-universidad-miguel-hern%C3%A1ndez-de-elche

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bioengineering Institute